Old Web
English
Sign In
Acemap
>
Paper
>
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (vol 12, 2016, 2021)
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (vol 12, 2016, 2021)
2021
Sho Iketani
Farhad Forouhar
Hengrui Liu
S. J. Hong
Fang-Yu Lin
Manoj S. Nair
Arie Zask
Yaoxing Huang
L. Xing
Brent R. Stockwell
Alejandro Chavez
David D. Ho
Keywords:
severe acute respiratory syndrome coronavirus 2
Virology
Chemistry
Protease
2019 20 coronavirus outbreak
Coronavirus disease 2019
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]